by Talking Medicines | Feb 25, 2022
Since everyone seems to be living their lives online these days, it makes sense this is where to find out what patients are really saying about their medicines. Now, U.K.- and New Jersey-based company Talking Medicines has developed an AI platform called PatientMetRx®...
by Talking Medicines | Aug 30, 2021
The team at Talking Medicines are delighted to have published an academic paper on the methodologies behind the classification of the patient voice by Alex et al. BMC Med Inform Decis Mak (2021) 21:244. This is part of the R&D work that has been completed in the...
by Talking Medicines | Jul 30, 2021
Talking Medicines partners with Closing Delta to help pharma accelerate digital transformation Data insights firm Talking Medicines, specialist in AI driven ‘social intelligence’ for the pharmaceutical industry, has formed a strategic partnership with digital...
by Talking Medicines | Jun 22, 2021
Trust is central to all human relationships and, in the context of a setting characterised by vulnerability such as in a clinical consultation, may be considered as the belief of the individual placing their trust that the trustee will care for their best interests....
by Talking Medicines | Jun 22, 2021
In randomised control trials (RCTs), the acknowledged backbone of the Pharmaceutical Industry, populations of patients are carefully selected and homogenised in one or several respects to minimise allocation bias, and are then treated separately in one aspect of their...
by Talking Medicines | Jun 21, 2021
Pharmaceutical companies are making a conscious decision to embrace digitalization and and the information revolution. This is because of the direct patient benefit from adopting data-driven approaches to research. The technology now has the potential to transform...
